A Lindblom
Overview
Explore the profile of A Lindblom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
134
Citations
2684
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hansson K, Lindblom A, Elg M, Lovgren A
Haemophilia
. 2015 Dec;
22(3):453-61.
PMID: 26635073
Background: Haemophilia A and B are treated with FVIII and FIX replacement therapy. Treatment may be complicated by inhibitory antibodies that require bypass therapy such as FEIBA(®) in which prothrombin...
2.
Agarwal D, Pineda S, Michailidou K, Herranz J, Pita G, Moreno L, et al.
Br J Cancer
. 2014 Feb;
110(4):1088-100.
PMID: 24548884
Background: Breast cancer is one of the most common malignancies in women. Genome-wide association studies have identified FGFR2 as a breast cancer susceptibility gene. Common variation in other fibroblast growth...
3.
Ohrmalm L, Gustafson I, Lindblom A, Norbeck O, Johansson J, Brune M, et al.
Bone Marrow Transplant
. 2013 Aug;
48(10):1366-7.
PMID: 23933762
No abstract available.
4.
Kulkarni R, Karim F, Glamocanin S, Janic D, Vdovin V, Ozelo M, et al.
Haemophilia
. 2013 May;
19(5):698-705.
PMID: 23651313
Recombinant factor VIII (rFVIII) products provide a safe and efficacious replacement therapy for prophylaxis and treatment of bleeding episodes in patients with severe haemophilia A. This multinational, open-label, non-controlled trial...
5.
Lentz S, Misgav M, Ozelo M, Salek S, Veljkovic D, Recht M, et al.
Haemophilia
. 2013 May;
19(5):691-7.
PMID: 23647704
Recombinant factor VIII (rFVIII) products provide a safe and efficacious replacement therapy for prophylaxis and treatment of bleeding episodes in patients with severe haemophilia A. This multinational, open-label, non-controlled trial...
6.
Widgren K, Magnusson M, Hagstam P, Widerstrom M, Ortqvist A, Einemo I, et al.
Euro Surveill
. 2013 Apr;
18(15):20447.
PMID: 23594578
Sixty per cent of the Swedish population received the monovalent AS03-adjuvanted pandemic influenza vaccine in the autumn of 2009. We assessed the age-specific effectiveness of this pandemic vaccine against hospitalisation...
7.
Lindblom A, Wallmenius K, Nordberg M, Forsberg P, Eliasson I, Pahlson C, et al.
Eur J Clin Microbiol Infect Dis
. 2012 Sep;
32(3):317-23.
PMID: 22961007
Patients seeking medical care with erythema migrans or flu-like symptoms after suspected or observed tick bite in the southeast of Sweden and previously investigated for Borrelia spp. and/or Anaplasma sp....
8.
Stevens K, Garcia-Closas M, Fredericksen Z, Kosel M, Pankratz V, Hopper J, et al.
Br J Cancer
. 2011 Oct;
105(12):1934-9.
PMID: 22033276
Background: Somatic mutations in phosphoinositide-3-kinase catalytic subunit alpha (PIK3CA) are frequent in breast tumours and have been associated with oestrogen receptor (ER) expression, human epidermal growth factor receptor-2 overexpression, lymph...
9.
Richter J, Strandberg K, Lindblom A, Strevens H, Karpman D, Wide-Swensson D
Transfus Med
. 2011 Jan;
21(3):211-3.
PMID: 21219489
No abstract available.
10.
Theodoratou E, Campbell H, Tenesa A, Houlston R, Webb E, Lubbe S, et al.
Br J Cancer
. 2010 Nov;
103(12):1875-84.
PMID: 21063410
Background: defective DNA repair has a causal role in hereditary colorectal cancer (CRC). Defects in the base excision repair gene MUTYH are responsible for MUTYH-associated polyposis and CRC predisposition as...